Healthcare

Meet your Healthcare Research team

Malin Corporation

Announcement of tender offer

Malin has announced that it intends to launch a tender offer for up to €150m at a price of €10.30/share. This is a 17% premium to yesterday’s closing price and a 4.4% discount to the...

CVS Group

H1 2025 trading update

CVS’ trading update for its H1 2025 December 31st reflects strong revenue growth driven by acquisitions. Earnings have increased and full-year guidance has been reiterated. There is...

hVIVO

FY2024 trading update and acquisition announced

2024 was a record year for hVIVO with stronger-than-expected top line growth and margin expansion. It moved into its new world leading facility, adding scale, and it launched new...

Uniphar

Stronger-than-expected organic growth drives an improved outlook

Uniphar’s trading update for FY2024 outlines stronger-than-expected growth in gross profits and EPS. Strong cashflows mean net debt is materially below forecast. Confidence in hitting...

hVIVO

New contract win

hVIVO has announced that hLAB, its standalone laboratory service provider, has won a new £2.7m laboratory contract – its largest standalone lab contract to date. This positive news...

hVIVO

Positive contract win and reiteration of FY2024 guidance

hVIVO has announced that it has won a contract for £11.5m with an existing top-tier global pharma customer. This will involve a human challenge study to test the customer’s antiviral...

Malin Corporation

Sale of Poseida unlocks significant value

Malin’s investee company, Poseida, which is listed in the US, is being acquired by Roche – triggering a substantial cash payment to Malin and upside in its intrinsic value. The tender offer...

CVS Group

Trading statement

CVS has issued a trading statement ahead of its AGM later today. Earnings growth in the first four months of FY2025 slowed, but the company remains confident of achieving full year...

Malin Corporation

Tender offer details

Malin has announced the details of its €45m tender offer, which is taking place post the disposal of its successful investment in CG Oncology. The tender price is set at €6.55 per...

hVIVO

Launch of hLAB standalone services

hVIVO has announced the launch of its hLAB service offering. This is a standalone business that it can offer for virology and immunology services. It follows the tripling of the...